Carlyle-backed Indegene makes another overseas acquisition
Indegene, a technology-led healthcare solutions provider to biopharmaceutical, biotech and medical devices companies, has acquired another overseas company to ramp up its service offerings. The Indian company, which is backed by US-based private equity firm Carlyle, has purchased medical writing consultancy firm Trilogy Writing & Consulting GmbH. Indegene said in a statement Trilogy's acquisition will ......
Deals Digest: Funding momentum slows further in shorter week
Capital raised by private equity and venture capital-backed startups slipped for the second consecutive week, as overall activity was subdued due to a three-day working week on account of Holi and Good Friday holidays. Overall funding raised by startups and companies backed by altrnative investors nearly halved this week to $236 ......
Indegene, Mamaearth parent get SEBI approval for IPO
Private equity and venture capital-backed firms Indegene, a pharma player and skincare brand Mamaearth’s parent Honasa Consumer have received approval from Securities and Exchange Board of India (Sebi) for their respective initial public offerings. Both companies had filed preliminary papers with the market regulator in December 2022, with an aim to ......
Carlyle makes a partial exit from IPO-bound Indegene
Private equity firm Carlyle has trimmed its stake in Indegene, just two years after teaming up with another investment firm to joint betting $200 million (Rs 1,500 crore then) on the healthtech venture. Carlyle had joined hands with Brighton Park Capital, a private investment firm that focuses on software, information services, ......
Silence Laboratories, four others raise early-stage funding
Privacy-tech startup Silence Laboratories, software-as-a-service (SaaS) startups Zvolv and Nurturev, construction material marketplace Bandhoo, and ambulance service provider Dial4242 raised early-stage funding, the companies said on Thursday. Silence Laboratories Silence Laboratories has raised $4.1 million (Rs 34 crore) in a pre-Series A funding round led by Pi Ventures. The round ......
Carlyle, two others to pare stakes in Indegene via IPO route
US private equity giant Carlyle and two other investors are planning to make partial exits from Indegene Ltd through an initial share sale of the technology-led healthcare solutions provider worth up to ₹3,200 crore. Carlyle along with Brighton Park Capital and the Nadathur Family Office are proposing to sell less than ......
Why Avendus is expanding its investment focus on manufacturing sector
Avendus Future Leaders Fund, the late-stage investment arm of financial services firm Avendus, is expanding the list of sectors it focuses on to include manufacturing, as it nears the end of deployment period for its second fund, a top executive told VCCircle. The firm, which is currently investing from the Avendus ......
Bourse-bound Indegene buys New York’s marketing firm CultHealth
Bengaluru-based Indegene Lifesystems Pvt Ltd, which provides clinical, commercial and marketing solutions to life sciences and pharmaceutical companies, has bought New York-based healthcare marketing agency CultHealth through its subsidiary ILSL Inc. However, the company did not disclose the size of the acquisition. With this buyout, Indegene will look to improve its portfolio ......
Indian healthtech in a soup as investors turn cautious on elusive profitability, lack of scale
The Indian healthtech sector may be facing a time of reckoning as investment dries up gradually. As the $6.5 billion sector grapples with a plethora of issues ranging from delayed profitability, stagnant scale to offline competition, investors now seek businesses that are relatively closer or have already turned the corner and ......
Indegene appoints bankers for IPO; Carlyle likely to exit company
Indegene Pvt. Ltd, a technology-led healthcare solutions provider has appointed bankers—JP Morgan India Pvt Ltd and Kotak Mahindra Capital Co Ltd for their forthcoming initial public offering (IPO) of the company, people aware of the matter said on condition of anonymity, adding that the company is likely to raise Rs ......
